Complete Pathologic Responses to Preoperative Chemoradiation in Two Patients with Adenocarcinoma of the Pancreas

Pancreas

Volumn 28, Issue 1, 2004, Pages 103-104

  Magnin, V ^a   Viret, F ^a   Moutardier, V ^a   Lelong, B ^a   Giovannini, M ^a   Monges, G ^b   Delpero, J R ^a  

^a Department of Radiotherapy ^*  (France)

^b INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CA 19-9 ANTIGEN; CISPLATIN; FLUOROURACIL; MITOMYCIN C; STREPTOZOCIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREATICODUODENECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; PREOPERATIVE CARE; TREATMENT OUTCOME;

EID: 0348048857     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200401000-00017     Document Type: Article

References (12)

1. Evans DB, Abbruzzese JL, Willett CG. Cancer of the pancreas. In: De Vita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology, 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2001:1126-1161.
2. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer. 1987;59:2006-2010.
3. Klinkenbijl JH, Jeekel J, Sahmoud, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg. 1999;230:782-784.
4. Neoptolemos JP, Dunn JA, Stocken DD, et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet. 2001;358:1576-1585.
5. White RR, Hurwitz HI, Morse MA, et al. Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas. Ann Surg Oncol. 2001;8:758-765.
6. Wanebo HJ, Glicksman AS, Verzeridis MP, et al. Preoperative chemotherapy, radiotherapy and surgical resection of locally advanced pancreatic cancer. Arch Surg. 2000;135:81-87.
7. Snady H, Bruckner H, Cooperman A, et al. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial. Cancer. 2000;89:314-327.
8. Mehta VK, Fisher G, Ford JA, et al. Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas. J Gastrointest Surg. 2001;5:27-35.
9. Therasse P, Arbuck SG, Eisenhower EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Nat Cancer Inst. 2000;92:205-216.
10. Beyer T, David WT, Tony B, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41:1369-1379.
11. Francois Y, Nemoz CJ, Baulieux J, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol. 1999;17:2396.
12. Magnin V, Moutardier V, Giovannini MH, et al. Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer. J Radiat Oncol Biol Phys. 2003;55:1300-1304.